Browsed by
Tag: patients

MGC Pharmaceuticals Ltd ships first-ever THC formulations direct to Brazilian patients via ONIX online platform

MGC Pharmaceuticals Ltd ships first-ever THC formulations direct to Brazilian patients via ONIX online platform

Brazil is a strategically important market with a population of over 210 million and a pharmaceutical market value of around A$24 billion per annum, with new patients registering daily for MGC Pharma products after the first week.

() has completed its first-ever shipments of the Mercury Pharma line, which includes high THC products, directly to patients in Brazil through a binding supply and distribution agreement with ONIX Empreendimentos e Participações.

The company has become the first globally to ship high THC formations directly to a patient’s door in Brazil, marking a first major operational achievement.

ONIX has launched the second generation of its CANTERAMED platform to help doctors better service their patients. 

This platform has facilitated the doctor’s practice with its protocols to use MGC Pharma products and register treatment results. 

CANTERAMED includes a telemedicine platform that connects patients with doctors trained to prescribe MGC Pharma products. 

“Rapidly increasing demand”

Co-founder and MD Roby Zomer said: “This is an incredible achievement as no other company has shipped high THC formulations directly to patients in Brazil before.

“We have been working closely with our Brazilian partner ONIX and remain confident that Brazil will be a huge strategically and commercially important region for us going forward.

“Feedback to date from patients in Brazil has been extremely positive and we are seeing rapidly increasing demand for our Mercury Pharma products.”

The shipment of Mercury Pharma branded products directly to patients is in compliance with Brazil’s Compassionate Use Program, following the receipt of patients’ prescriptions provided by an ONIX referring doctor.

ONIX has more than 100 referring doctors in Brazil able to prescribe cannabinoid products under the Compassionate Use Program and is targeting to have more than 300 referring doctors by the end of calendar 2020 as well as more than 1,000 by mid-2021.

Read the rest
New Analysis Shows Contract Pharmacies Financially Gain From 340B Program With No Clear Benefit to Patients

New Analysis Shows Contract Pharmacies Financially Gain From 340B Program With No Clear Benefit to Patients

New Analysis Shows Contract Pharmacies Financially Gain From 340B Program With No Clear Benefit to Patients

PR Newswire

WASHINGTON, Oct. 8, 2020

WASHINGTON, Oct. 8, 2020 /PRNewswire/ — Today, the Berkeley Research Group (BRG) published an analysis of historical trends in 340B contract pharmacy arrangements. The findings conclude that the growth in the number of these arrangements is fueling explosive growth in the program at large and driving the 340B program farther and farther away from its original intended goal of providing discounted medicines to safety-net entities treating uninsured and vulnerable patients. 

New Analysis Shows Contract Pharmacies Financially Gain From 340B Program With No Clear Benefit to Patients
New Analysis Shows Contract Pharmacies Financially Gain From 340B Program With No Clear Benefit to Patients

Congress created the 340B program to help safety-net providers, including certain qualifying hospitals and federally-funded clinics, access discounts on prescription medicines for low-income or uninsured patients. In 2010, a Health Resources and Services Administration (HRSA) policy opened the door to allow all 340B entities to contract with an unlimited number of for-profit retail pharmacies (e.g., CVS, Walgreens) to dispense 340B medicines. While this policy may have been intended to improve patient access to needed medications, it had the misguided effect of creating an opening that allowed for-profit vendors, pharmacies and pharmacy benefit managers to exploit the program and make a profit on 340B sales – sales intended to benefit low-income and vulnerable patients.

“It is clear that contract pharmacies have leveraged market power to drive unprecedented program growth and siphon money out of the program and away from vulnerable patients,” said Stephen J. Ubl, president and chief executive officer of the Pharmaceutical Research and Manufacturers of America (PhRMA). “I urge lawmakers to consider the results of this analysis and pursue policies that ensure the 340B program benefits vulnerable patients rather than just line the pockets of for-profit corporations.”

Read the rest
300,000 patients in Cook County could lose insurance if Obamacare repealed, analysis warns

300,000 patients in Cook County could lose insurance if Obamacare repealed, analysis warns

Cook County’s public health system would take a $1.4 billion hit and more than 300,000 residents who depend on the system would lose their insurance if Obamacare is repealed, according to an analysis announced Wednesday.

The estimates reflect the number of patients who are enrolled in Medicaid expansion plans made possible by the 2010 law and who receive treatment at Cook County’s public health system, officials said.

Cook County President Toni Preckwinkle, joined by six Democrats from Illinois’ congressional delegation, said she believes the law, known as the Affordable Care Act, is in danger because President Donald Trump’s administration has taken aim at repealing it and his Supreme Court nominee, Amy Coney Barrett, has been critical of it.

“A repeal of the ACA would not only financially cripple Cook County Health by dramatically increasing the amount of uncompensated health care we already provide, it would be catastrophic to the patients we serve,” Preckwinkle said at a news conference.

Health system officials say they already provide half of the charitable health care in Cook County.

Debra Carey, interim chief executive of Cook County Health, said the $1.4 billion estimated loss represents revenue the health system brings in through Affordable Care Act plans and a projection that half of more than 300,000 patients depending on the health system would become uninsured and would require charity care.

Cook County Health, which includes John H. Stroger Hospital on the West Side and Provident Hospital on the South Side, treats patients enrolled in multiple Affordable Care Act health plans, Carey said.

“This is a real threat to our organization, the progress we have made under the Affordable Care Act and the people who have been served by it,” Carey said.

Carey may not be at the top job of the county health system much longer

Read the rest